TXNIP and metabolic dysfunction-associated steatotic liver disease: SalA extenuated hepatic lipid accumulation and inflammation in HFD-induced NAFLD, and these protective effects were associated with the TXNIP/NLRP3 pathway (Ding et al., 2016).